LMC Diabetes is an industry leader, providing Phase I-IV clinical trial services in nine sites, across three Canadian provinces. Together with Manna Research who primarily focuses on primary care studies provides Sponsors, CRO’s & ARO’s access to one of the largest fully owned and operated clinical research site networks within Canada at thirteen sites across four provinces.

LMC Diabetes’ primary focus is diabetes, obesity, metabolic, and cardiovascular disease. Manna Research is a combination of diseases but focuses 30% of their efforts in diabetes and metabolic disease.